MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software
solutions developer and a service provider for image interpretation and
management in oncology clinical trials and clinical routine, announced
today it will demonstrate its Lesion Management Solutions -LMS- clinical
application portfolio together with Canon at ITEM, April 13-15, 2012 in
Yokohama, Japan.
This joint presentation results from the strategic partnership agreement
signed between Canon Inc and MEDIAN Technologies in July, 2011, with
three major objectives:
-
To develop new Computer-Aided Diagnosis/Detection (CAD) products and
services,
-
To make these innovative solutions available to hospitals and
biopharmaceutical companies through a cloud-based Software as a
Service (SaaS) offering,
-
To establish major clinical partnerships in Japan and Asia in
particular to validate new imaging solutions developed through the
partnership.
"We have been working very closely with CANON Inc. since the
signature of our long-term partnership", said Gerard Milhiet, MEDIAN
Executive Vice President and co-founder."We are thrilled to support
CANON in exploring new opportunities in the region by leveraging
existing LMS applications as well as upcoming co-developed LMS solutions
in the context of oncology clinical routine and clinical trials,
healthcare IT solutions, and lung cancer screening".
International team releases recommendations for AI use in neuro-oncology